 |
| Karen Strauss |
Karen Strauss, a 30-year veteran of Ketchum, has joined M Booth Health as chief strategy & innovation officer, a new post.
Reporting to CEO Timothy Bird, Strauss will helm the firm's strategic & creative planning function and explore synergies with M Booth.
At Ketchum, Strauss was most recently executive creative director/health and prior to a reorganization held the chief global strategy and creative officer slot. Earlier, she was chief innovation officer and head of both the healthcare and consumer marketing practices.
Bird praised Strauss for her "ability to devise imaginative, new ways to reach and inform healthcare professionals and patients."
He looks forward to working with her to "capitalize on trends shaping the world of healthcare, including the mounting burden of chronic diseases like diabetes, payer pressures on pharma to demonstrate better outcomes, and a growing consumer focus on prevention and self-care.”
M Booth Health is the former US arm of Britain's Health Unlimited, which was the mash-up of Cooney Waters Group and Corkery Group.
In October, Next Fifteen Communications acquired and rebranded it as M Booth Health, which operates as a separate company reporting to M Booth CEO Dale Bornstein.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
